Genomic landscapes of cancers: prospects for targeted therapies

Pharmacogenomics. 2007 Dec;8(12):1629-33. doi: 10.2217/14622416.8.12.1629.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Class I Phosphatidylinositol 3-Kinases
  • Connectin
  • ErbB Receptors / genetics
  • Genomics*
  • Guanine Nucleotide Exchange Factors / genetics
  • Humans
  • Muscle Proteins / genetics
  • Mutation
  • Neoplasms / genetics*
  • Neoplasms / therapy
  • PTEN Phosphohydrolase / genetics
  • Phosphatidylinositol 3-Kinases / genetics
  • Protein Kinases / genetics
  • Protein Serine-Threonine Kinases
  • Rho Guanine Nucleotide Exchange Factors

Substances

  • Connectin
  • Guanine Nucleotide Exchange Factors
  • Muscle Proteins
  • Rho Guanine Nucleotide Exchange Factors
  • TTN protein, human
  • Protein Kinases
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human
  • ErbB Receptors
  • OBSCN protein, human
  • Protein Serine-Threonine Kinases
  • PTEN Phosphohydrolase
  • PTEN protein, human